Summary
Thirty-three patients with advanced colorectal carcinoma were entered on a phase II trial of weekly IV aminothiadiazole (175 mg/m2 escalated to 200 mg/m2) with concomitant allopurinol and non-steroidal anti-inflammatory agents (NSAID's). Toxicity was predominantly GI, cutaneous, and chest pain/dyspnea. Twenty-five percent of patients had grade 3 or 4 toxicity. There were no responses in 27 evaluable patients. Median survival was 12 months. Aminothiadiazole, at higher doses than used in previous reports, when given with NSAID's, had no significant activity against large bowel cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stewart JA, Ackerly CC, Myers CF, Newman RA, Krakoff IH: Clinical and clinical-pharmacologic studies of 2-amino-1,3,4-thiadiazole (A-TDA:NSC 4728). Cancer Chemother Pharmacol 16:287–291, 1986
Locker GY, Khandekar JD, Krauss S, Relsel H, Hoeltgen T, Wolter J, Haid M, Hoffman R, Blough R, Johnson C: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep 71:649–650, 1987
Shevrin DH, McGuire WP, Lanzotti V, Krauss S, Blough R, Cobleigh M, Johnson C, Lad T, Kukla L: Phase II trial of aminothiadiazole in advanced non-small cell lung cancer. Cancer Treat Rep 70:417–418, 1986
Locker G, Strond W, Khandekar J, Kram J, Khandekar A, Johnson C: Phase I trial of aminothiadiazole (ATDA) in patients with malignancy: an Illinois Cancer Council (ICC) study. Recent Advances in Chemotherapy: Proceedings 16th International Congress of Chemotherapy 16:746.1–746.2, 1989
Locker G, Khandekar J, Kram J, Johnson C: Aminothiadiazole (ATDA) in the treatment of advanced colorectal carcinoma: Illinois Cancer Council experience. Proceedings, American Society Clinical Oncology 8:113, 1989
Shevrin D, Wade J, Kilton L, Locker G, Kucuk O, Weidner L, Blough R: Aminothiadiazole in advanced non-Hodgkin's lymphoma: an Illinois Cancer Council phase II study. Blood 74:240a (suppl), 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Locker, G.Y., Kilton, L., Khandekar, J.D. et al. High-dose aminothiadiazole in advanced colorectal cancer. Invest New Drugs 12, 299–301 (1994). https://doi.org/10.1007/BF00873044
Issue Date:
DOI: https://doi.org/10.1007/BF00873044